Drugs / Gadolinium contrast
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02584413 Background | Apr 2013 → Feb 2019 | neurofibromatosis type 1 | Washington University School of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gadolinium contrast | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02584413 ↗ |
| Modality | Diagnostic / imaging agent | “routine clinical brain MRI with gadolinium contrast” NCT02584413 ↗ |